<DOC>
	<DOCNO>NCT01793038</DOCNO>
	<brief_summary>Polycystic ovarian syndrome ( PCOS ) condition characterize infertility , infrequent period amenorrhea irregular bleeding plus anovulatory infertility . Clomid standard first drug treatment ovulation induction . Ovulation conception occur approximately 75 30 percent case respectively . Cases ovulate response dos clomid 150 mg/day know clomid resistant PCOS .</brief_summary>
	<brief_title>Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH Clomiphene Resistant Infertile PCOS Women</brief_title>
	<detailed_description>To test whether CC co- treatment chronic low dose HP uFSH versus lirizole plus chronic low dose HP uFSH CC resistant PCOS yield comparable result term , ovulation rate , low follicle number , low HP uFSH dose , good outcome term pregnancy rate , good cost-effectiveness ratio , low multiple pregnancy rate , low cycle cancellation .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>CC resistant PCOS Infertile Females Age 1838 Hyperprolactinaemia Cushing syndrome Adult onset adrenal hyperplasia Age &gt; 38 Other infertility factor couple PCOS : male factor , tubal factor , edometriosis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>PCOS</keyword>
	<keyword>clomiphene citrate resistant PCOS</keyword>
	<keyword>Aromatase inhibitor</keyword>
</DOC>